Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Cassiopea S.p.A.
  6. Summary
    SKIN   IT0005108359

CASSIOPEA S.P.A.

(SKIN)
  Report
Delayed Quote. Delayed Swiss Exchange - 07/29 11:31:46 am
42 CHF   +0.48%
05:49aCASSIOPEA S P A : H1 Loss Swells to $7 Million
MT
01:07aCASSIOPEA S P A : Announces Results for First Half of 2021
PU
01:07aCASSIOPEA S P A : Half Year 2021 Financial Results Presentation
PU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
07/23/2021 07/26/2021 07/27/2021 07/28/2021 07/29/2021 Date
46.1(c) 44(c) 42.4(c) 41.8(c) 42 Last
2 971 28 467 8 486 3 139 4 284 Volume
-1.07% -4.56% -3.64% -1.42% +0.48% Change
More quotes
Estimated financial data (e)
Sales 2021 15,1 M 18,0 M 18,0 M
Net income 2021 -25,5 M -30,2 M -30,2 M
Net Debt 2021 4,50 M 5,35 M 5,35 M
P/E ratio 2021 -21,4x
Yield 2021 -
Sales 2022 63,7 M 75,6 M 75,6 M
Net income 2022 -10,2 M -12,1 M -12,1 M
Net Debt 2022 2,70 M 3,21 M 3,21 M
P/E ratio 2022 -32,0x
Yield 2022 -
Capitalization 417 M 492 M 495 M
EV / Sales 2021 27,8x
EV / Sales 2022 6,59x
Nbr of Employees 11
Free-Float 41,2%
More Financials
Company
Cassiopea SpA is an Italy-based company engaged in the biotechnology and medical research industry. The Company is a clinical stage specialty pharmaceutical company focused on developing and commercializing innovative and differentiated medical dermatology products. The Company's current focus is on the topical treatment of acne, androgenic alopecia (''AGA'') and genital warts. Its portfolio comprises four clinical... 
More about the company
Ratings of Cassiopea S.p.A.
Trading Rating : 
Investor Rating :  -
ESG Refinitiv : 
-
More Ratings
All news about CASSIOPEA S.P.A.
05:49aCASSIOPEA S P A : H1 Loss Swells to $7 Million
MT
01:07aCASSIOPEA S P A : Announces Results for First Half of 2021
PU
01:07aCASSIOPEA S P A : Half Year 2021 Financial Results Presentation
PU
01:07aCASSIOPEA S P A : Half Year Report 2021
PU
01:02aEQS-ADHOC : Cassiopea Announces Results for First -2-
DJ
01:02aEQS-ADHOC : Cassiopea Announces Results for First Half of 2021
DJ
07/26CASSIOPEA S P A : Enters License, Supply Deals for Acne Treatment in North Ameri..
MT
07/26Sun Pharmaceutical Industries Ltd. and Cassiopea SpA Announces the Signing of..
CI
07/26CASSIOPEA S P A : SpA and Sun Pharma Announce Signing of Licenseáand Supply Agre..
EQ
07/26EQS-ADHOC : Cassiopea SpA and Sun Pharma Announce Signing of License and Supply ..
DJ
07/22CASSIOPEA S P A : Test 1
PU
06/01CASSIOPEA S P A : Jefferies Virtual Healthcare Conference Presentation
PU
04/29CASSIOPEA S P A : Announces Results of AGM 2021
PU
04/29CASSIOPEA S P A : announces results of AGM 2021
EQ
04/29EQS-ADHOC : Cassiopea announces results of AGM 2021
DJ
More news
News in other languages on CASSIOPEA S.P.A.
02:01aCassiopea vise une rentabilité opérationnelle en 2021
01:56aBei Cassiopea rücken nach Akne-Kooperation Halbjahreszahlen in Hintergrund
01:02aEQS-ADHOC : Cassiopea gibt Ergebnisse des 1. Halbjahres 2021 bekannt
01:02aCassiopea gibt Ergebnisse des 1. Halbjahres 2021 bekannt
07/26Cassiopea conclut un accord de licence avec Sun pour le traitement de l'acné
More news
Chart CASSIOPEA S.P.A.
Duration : Period :
Cassiopea S.p.A. Technical Analysis Chart | SKIN | IT0005108359 | MarketScreener
Technical analysis trends CASSIOPEA S.P.A.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Last Close Price 38,77 €
Average target price 54,15 €
Spread / Average Target 39,7%
EPS Revisions
Managers and Directors
Diana Harbort Chief Executive Officer & Executive Director
Pierpaolo Guzzo Chairman & Chief Financial Officer
Luigi Moro Chief Scientific Officer
Alessandro Mazzetti Chief Medical Officer
Marco Pasero Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
CASSIOPEA S.P.A.-13.81%492
GILEAD SCIENCES, INC.20.25%87 868
BIONTECH SE284.51%75 705
WUXI APPTEC CO., LTD.36.10%68 994
REGENERON PHARMACEUTICALS21.38%60 726
VERTEX PHARMACEUTICALS-14.43%52 353